BG
MEDP icon

Bahl & Gaynor’s Medpace MEDP Stock Holding History

Bahl & Gaynor’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-26,435
Closed -$959K – 408
2017
Q4 		$959K Buy
26,435
+435
+2% +$15.2K 0.01% 282
2017
Q3 		$829K Buy
26,000
+4,085
+19% +$125K 0.01% 278
2017
Q2 		$635K Sell
21,915
-13,385
-38% -$375K 0.01% 308
2017
Q1 		$1.05M Buy
+35,300
New +$1.14M 0.01% 247

Other funds holding MEDP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BCA
Bernzott Capital Advisors Camarillo, California $250M AUM 26.89% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
GIP
Granite Investment Partners El Segundo, California $1.63B AUM 38.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

Bahl & Gaynor's MEDP Position: Q1 2018 in Review

Bahl & Gaynor sold out of Medpace (MEDP) in Q1 2018, closing a stake of 26,435 shares — an estimated $959K sold.

Bahl & Gaynor first reported a position in MEDP in Q1 2017 and held it in 4 quarters. The position peaked at $1.05M in Q1 2017. 113 funds tracked by Wall St. Rank hold MEDP as of Q1 2018.

  • Bahl & Gaynor reported no remaining Medpace position as of Q1 2018 after selling out during the quarter.
  • Bahl & Gaynor sold 26,435 Medpace shares in Q1 2018, an estimated $959K.
  • Bahl & Gaynor first reported a position in Medpace in Q1 2017 and held it in 4 quarters.
  • Bahl & Gaynor's Medpace position peaked at $1.05M in Q1 2017.
  • 113 funds tracked by Wall St. Rank held Medpace as of Q1 2018.

Based on Bahl & Gaynor's 13F filing for Q1 2018, filed 11 May 2018.